The invention relates to a medicament, the combination of active ingredients of which is made up of a retinoid selected from the group of acitretin [9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid], etretinate [ethyl 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoate], isotretinoin [3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid] and tretinoin [3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid] and a hormone combination with contraceptive action made up of an oestrogen and a gestagen component and a dosage form made up of at least 28 daily units, of which the last 7-3 daily units have only the retinoid as active ingredient and the remaining daily units also have the hormone-containing active ingredient combination and the use thereof for the treatment of acne, seborrhea or psoriasis.

IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jul 3, 2008
  • Application: Dec 19, 2007
    WO EP 2007011143 W
  • Priority: Dec 22, 2006
    DE DE 102006062119 A

Download Citation

Sign in to the Lens